Sign In

Ricardo Viana

Executive Director, Global Value and Access Disease Team Lead at Novartis Oncology

Ricardo Viana is a pharmaceutical industry professional with extensive experience in global value and access for oncology treatments. He currently holds the position of Executive Director, Global Value and Access Disease Team Lead at Novartis Oncology.14 Viana has a strong academic background, holding a PharmD and a PhD in biochemistry.4

At Novartis, Viana has been involved in various research projects and economic evaluations related to cancer treatments, particularly in the field of chronic myeloid leukemia (CML).13 He has contributed to studies assessing the cost-effectiveness of different tyrosine kinase inhibitors used in CML treatment.23

Prior to his current role, Viana worked in consultancy, as a clinical advisor, and in academia.4 His expertise spans across areas such as market access, health economics, and outcomes research in the pharmaceutical sector.34

Viana has authored and co-authored several scientific publications, demonstrating his commitment to advancing knowledge in his field.123 His work often focuses on the economic aspects of cancer treatments, aiming to improve patient access to effective therapies while considering healthcare system constraints.23

Highlights

A Systematic Literature Review of the Economic Evaluations of ...
Economic Model to Evaluate the Cost-Effectiveness of Second-Line ...
Oct 25 · journals.plos.org
Author Info | PLOS ONE

Related Questions

What are Ricardo Viana's main responsibilities at Novartis Oncology?
How has Ricardo Viana contributed to the field of oncology?
What is Ricardo Viana's educational background?
What projects has Ricardo Viana led at Novartis?
How does Ricardo Viana's work impact patient access to cancer treatments?
Ricardo Viana
Add to my network

Location

Switzerland